Taiwan FDA registration 2ffa32d79fe515e842c8efbaf1d3474c
Reva portable blood glucose testing system
TW: 露華攜帶型血糖測試系統
Taiwan·Risk Class 2·NOVA BIOMEDICAL TAIWAN CORP.·Registered Sep 13, 2018 – Sep 13, 2028ActiveRegistration details
- Analysis ID
- 2ffa32d79fe515e842c8efbaf1d3474c
Company information
- Manufacturer
- NOVA BIOMEDICAL TAIWAN CORP.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- NOVA BIOMEDICAL TAIWAN CORP.
Product details
- Intended Use
- This product provides diabetic patients with home measurement of blood glucose value, which can measure the microvascular whole blood collected through the fingertip and the microvascular blood glucose value of the arm before ectopic blood collection.
- Product Type (Level 1)
- I General, Plastic Surgery & Dermatology;; A Clinical Chemistry and Clinical Toxicology
- Product Type (Level 2)
- I.4800 Manual instruments for general surgery; A.1345 Glucose Test System
- Import Information
- Domestic
Dates and status
- Registration Date
- Sep 13, 2018
- Expiry Date
- Sep 13, 2028
About this record
Access comprehensive regulatory information for Reva portable blood glucose testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2ffa32d79fe515e842c8efbaf1d3474c and manufactured by NOVA BIOMEDICAL TAIWAN CORP.. The authorized representative in Taiwan is NOVA BIOMEDICAL TAIWAN CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices